The Irvine, California-based company will now market its test to clinical labs throughout the UK for patient testing.

MHRA registration authorizes hp+detect™ for commercial sale in Great BritainActive Commercialization: Biomerica is in active ...

| DelveInsight The H. pylori infection market is evolving as treatment strategies shift toward optimized, targeted combination therapies, including triple- and quadruple-drug regimens, bismuth-based ...

The H. pylori infection market is evolving as treatment strategies shift toward optimized, targeted combination therapies, including triple- and quadruple-drug regimens, bismuth-based therapies ...

RedHill Biopharma announces full sales and operational launch of Talicia in US: Raleigh, North Carolina Friday, February 27, 2026, 13:00 Hrs [IST] RedHill Biopharma Ltd., a specia ...

The findings of a new study suggest a possible association between H. pylori infection and the pathophysiology of vitiligo. Based on this link, H. pylori eradication therapy may serve as ...

A doctor yesterday reminded people not to take certain types of drugs before getting a stool antigen test for Helicobacter pylori amid a one-time government-funded testing program for people aged 45 ...

Most men have about a 90% improvement in prostate symptoms immediately after the procedure, which was then reduced to about 50% improvement over their baseline after five years. UroLift is very ...

RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced ...

A single bacterium that silently colonizes the stomachs of billions of people could be responsible for roughly 12 million ...

H. pylori is widely recognised by clinicians as one of the leading causes of chronic gastric conditions in the country. For weeks, Epiphanie Nyiransabimana watched her son struggle with persistent ...